Showing results (241-250 of 424) with videos related to
Sort By:
Pageof 43
European Journal of Gastroenterology & Hepatology|December 25, 2004
Long-term therapy with lamivudine in renal transplant recipients with chronic hepatitis BDominique Thabut, Vincent Thibault, Brigitte Bernard-Chabert, et al.Journal of Clinical Gastroenterology|July 8, 2009
Assessment of liver fibrosis and steatosis in PBC with FibroScan, MRI, MR-spectroscopy, and serum markersMireen Friedrich-Rust, Cindy Müller, Anne Winckler, et al.Journal of Gastrointestinal and Liver Diseases : JGLD|June 13, 2020
Identification of Patients with Advanced Fibrosis Due to Nonalcoholic Fatty Liver Disease: Considerations for Best PracticeSalvador Augustin, Aijaz Ahmed, Naim Alkhouri, et al.Journal of Hepatology|September 14, 2019
A cross-sectional study of the public health response to non-alcoholic fatty liver disease in EuropeJeffrey V Lazarus, Mattias Ekstedt, Giulio Marchesini, et al.Hepatology (Baltimore, Md.)|April 30, 2019
Defining Improvement in Nonalcoholic Steatohepatitis for Treatment Trial Endpoints: Recommendations From the Liver ForumAmanda Cheung, Brent A Neuschwander-Tetri, David E Kleiner, et al.JHEP Reports : Innovation in Hepatology|March 18, 2021
European 'NAFLD Preparedness Index' - Is Europe ready to meet the challenge of fatty liver disease?Jeffrey V Lazarus, Adam Palayew, Patrizia Carrieri, et al.Journal of Hepatology|February 28, 2002
Polymorphonuclear neutrophils are a source of hepatocyte growth factor in patients with severe alcoholic hepatitisJulien Taïeb, Charlotte Delarche, Valérie Paradis, et al.Journal of Hepatology|April 12, 2002
Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AHPhilippe Mathurin, Charles L Mendenhall, Robert L Carithers, et al.The New England Journal of Medicine|April 30, 2025
Phase 3 Trial of Semaglutide in Metabolic Dysfunction-Associated SteatohepatitisArun J Sanyal, Philip N Newsome, Iris Kliers, et al.Cell Reports. Medicine|December 30, 2020
Dihydroceramides in Triglyceride-Enriched VLDL Are Associated with Nonalcoholic Fatty Liver Disease Severity in Type 2 DiabetesAurélie Carlier, Franck Phan, Anaïs Szpigel, et al.Pageof 43